Malaysia IV Equipment Market Size, Share,Trends, Growth Analysis Report, 2031

Name: Malaysia IV Equipment Market Size, Share,Trends, Growth Analysis Report, 2031
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Malaysia IV Equipment Market analysis

Part of: IV Equipment Market (Global)

The Malaysia IV Equipment Market was valued at $29.59 Million in 2026 and projected to reach to $37.87 Million by 2031, representing a compound annual growth rate of 5.1%. Malaysia's IV Equipment Market is poised for steady growth through 2031, supported by increasing healthcare expenditure and modernization of medical facilities across the country.

Malaysia IV Equipment Market (2026-2031) : Size and Share

CAGR of

USD Million

Malaysia IV Equipment Market Trends and Insights

This steady growth reflects Malaysia's advancing healthcare infrastructure and increasing demand for reliable intravenous delivery systems across hospitals, clinics, and ambulatory care settings.
Malaysia's market expansion is driven by rising patient volumes, improved healthcare accessibility, and growing adoption of modern medical technologies in both urban and emerging regional healthcare facilities. The IV Equipment Market in Malaysia is supported by a robust pharmaceutical sector and strengthening regulatory frameworks that ensure product quality and safety standards.
Malaysia's healthcare expenditure continues to rise, with both public and private sector investments fueling demand for advanced infusion pumps, IV sets, and related consumables.
Between 2026 and 2031, Malaysia is expected to see increased penetration of automated infusion systems and smart IV technologies, particularly in tertiary care centers and specialized treatment facilities..

Key Market Statistics

CAGR (2026-2031) 5.1% CAGR
Market Size, 2026 ~USD 29.59 Million
Forecast, 2031 ~USD 37.87 Million
Country Malaysia

Malaysia IV Equipment Market Overview

Market Size & Growth :

Malaysia's IV Equipment Market is valued at USD 29.59 million in 2026, with projected growth to USD 37.87 million by 2031, representing a steady 5.1% CAGR driven by healthcare modernization.

Healthcare Infrastructure Expansion :

Malaysia's advancing healthcare infrastructure and government investments in medical facilities are driving increased adoption of IV delivery systems across public and private healthcare institutions.

Diverse End-User Base :

Strong demand across hospitals, clinics, and ambulatory care settings reflects Malaysia's growing patient population and expanding outpatient treatment capabilities.

Regional Healthcare Positioning :

As a Southeast Asian healthcare hub, Malaysia's IV equipment market benefits from regional medical tourism and cross-border healthcare demand, supporting sustained market expansion.

Malaysia IV Equipment Market Dynamics

The market benefits from Malaysia's position as a regional healthcare destination and growing emphasis on quality patient care standards.
Rising prevalence of chronic diseases and expanding ambulatory care services are key growth catalysts.
Government initiatives to strengthen healthcare infrastructure and private sector investments in medical technology will continue to drive demand for advanced IV delivery systems.
The market's 5.1% CAGR reflects a balanced growth trajectory aligned with Malaysia's economic development and healthcare sector maturation..

Related Ecosystem

Medical Devices

Top Technologies

Polymerase Chain Reaction (PCR)
Magnetic Resonance Imaging (MRI)
Disposable Autoinjectors
Pulse Oximeters
Blood Pressure Monitors

Top Companies

Medtronic plc
Abbott Laboratories
Stryker Corporation
Becton, Dickinson and Company
CONMED Corporation

Key Takeaways

Malaysia's IV Equipment Market is valued at USD 29.59 million in 2026 and will reach USD 37.87 million by 2031.
Malaysia's market is growing at a 5.1% CAGR, driven by healthcare infrastructure development and rising patient demand.
Malaysia's private healthcare sector and government health initiatives are key growth catalysts for IV equipment adoption.
Malaysia is experiencing increased adoption of smart infusion technologies and automated IV delivery systems in major medical centers.

IV Equipment Market Report Scope

Report Metric	Details
Base Year	2026
Fastest Growing Segment	NEEDLE-FREE CONNECTORS & EXTENSION SETS (Type)
Forecast Period	2026�2031
Growth Rate	CAGR of 6.1% from 2026 to 2031
Largest Segment	HOSPITALS (End User)
Market Size Base Year (Billions)	~USD 17.79 (2026)
Revenue Forecast (Billions)	~USD 23.92 (2031)
Segments Covered	Type, Application, End User

Malaysia IV Equipment Market Report Segmentation

3 segment dimensions are covered across the global market.

By Type

Analgesia/Pain Management
Antibiotic/Antimicrobial Iv Therapy
Critical Care & Vasoactive Drug Infusion
Critical Care Nutrition
Gastrointestinal Disorders
Immunotherapy
Infusion Pumps
Iv Administration Sets & Tubing
Iv Catheters
Iv Drip Chambers
Needle-Free Connectors & Extension Sets
Neonatal & Pediatric Parenteral Nutrition
Oncology (Iv Chemotherapy)
Other Blood & Blood Products Transfusion Applications
Other Iv Equipment
Other Parenteral Nutrition Applications
Plasma Transfusion
Platelet Transfusion
Red Blood Cell Transfusion
Securement & Stabilization Devices
Sedation & Anesthesia Infusion

By Application

Blood & Blood Products Transfusion
Diagnostic Testing
Fluid & Electrolyte Replacement
Medication Administration
Other Applications
Parenteral Nutrition (Pn)

By End User

Ambulatory Surgical Centers
Ambulatory Surgical Centers (Ascs)
Home Care Settings
Hospitals
Other End Users
Outpatient Infusion & Specialty Clinics

Target Audience

Medical Device Manufacturers : Evaluate Malaysia's IV equipment market potential for product launches, localization strategies, and competitive positioning in Southeast Asia's growing healthcare sector.
Healthcare Facility Operators : Understand market trends, procurement patterns, and equipment demand forecasts to optimize inventory planning and supplier negotiations in Malaysia.
Investment & Private Equity Firms : Assess Malaysia's IV equipment market attractiveness, growth trajectory, and investment opportunities in healthcare infrastructure and medical technology sectors.
Healthcare Consultants & Advisors : Leverage Malaysia-specific market data to advise clients on market entry strategies, competitive positioning, and business development in the IV equipment sector.
Government & Healthcare Policymakers : Use market insights to inform healthcare infrastructure planning, procurement policies, and strategic initiatives supporting Malaysia's medical device ecosystem development.

Key Companies in the Malaysia IV Equipment Market

Company	HQ	Ownership	Strongest segments
KINDRED HEALTHCARE INC.	United States	Private Company	Long-term acute care hospital drug utilization,Inpatient rehabilitation facility drug utilization,Contract rehabilitation and ancillary services,
ATS AUTOMATION TOOLING SYSTEMS INC	Canada	Public Company	Turnkey automated manufacturing and assembly systems,Pre- and post-automation services,Contract manufacturing and value engineering,
CONVATEC	United Kingdom	Public Company	Advanced wound care,Ostomy care,Continence and critical care,
IRADIMED CORPORATION	United States	Public Company	MRidium 3870/3860+ MRI-compatible infusion pump systems and disposables,3880 MRI-compatible patient vital signs monitoring system and accessories,3600 FMD1 ferromagnetic detection devices and remote alarm units,
POLY MEDICURE LTD.	India	Public Company	Infusion & Transfusion Therapy,Critical Care & Anesthesia/Respiratory,Dialysis & Renal Care,
CONMED CORPORATION	United States	Public Company	Sports medicine & soft tissue fixation (BioBrace, Y-Knot, TruShot, Agro Knotless),Powered large & small bone systems (Hall brand),General surgery � insufflation & smoke management (AirSeal, Buffalo Filter),
MALLINCKRODT PLC	Ireland	Private Company	Autoimmune and rare disease therapies,Neurology and rheumatology specialty products,Neonatal respiratory and critical care therapies,
BECTON, DICKINSON AND COMPANY	United States	Public Company	Medical Essentials (syringes, needles, catheters, sharps, specimen collection),Connected Care (infusion, medication management, automation, informatics),BioPharma Systems (prefillable drug delivery, CSTD, hazardous drug detection),
BAXTER	United States	Public Company	Medical Products & Therapies (IV solutions, infusion systems, parenteral nutrition, dialysis-related therapies),Healthcare Systems & Technologies (smart beds, OR integration, monitoring, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),
FRESENIUS SE & CO. KGAA	Germany	Public Company	Fresenius Helios (hospitals and outpatient care),IV generics and IV fluids,Clinical nutrition (enteral and parenteral),
ICU MEDICAL, INC.	United States	Public Company	Infusion pumps and hardware,Infusion consumables and vascular access (Clave, Neutron, Tego, disinfection caps),IV solutions and diluents,
TERUMO CORPORATION	Japan	Public Company	Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
MOOG, INC.	United States	Public Company	Military Aircraft,Commercial Aircraft,Space and Defense,
TELEFLEX INCORPORATED	United States	Public Company	Vascular access & emergency medicine (Arrow, EZ-IO, QuikClot, FAST1),Interventional cardiology & peripheral (GuideLiner, Turnpike, MANTA, DCBs, stents),Surgical products (Weck clips, MiniLap, staplers, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	China	Public Company	Patient monitoring, anesthesia, ventilators, and life-support,Ultrasound and medical imaging (radiology, emergency, critical care),In-vitro diagnostics (CLIA, chemistry, hematology),
CARDINAL HEALTH	United States	Public Company	Pharmaceutical Distribution (Branded & Generic),Specialty Pharmaceutical & Manufacturer Services,Medical Products & Cardinal-Branded Devices,
AVANOS MEDICAL, INC.	United States	Public Company	Digestive health (Mic-Key, Corpak, NeoMed),Non-opioid surgical pain and recovery (ON-Q, ambIT, Game Ready),Interventional pain (COOLIEF, Trident, Esentec RFA),
NIPRO	Japan	Public Company	Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceuticals (generic and kit products),
JMS CO., LTD.	United States	Public Company	U.S. Retail Coffee,U.S. Retail Pet Foods and Snacks,U.S. Retail Frozen Handheld and Spreads,

KINDRED HEALTHCARE INC.

Kindred Healthcare Inc. is a private United States-based healthcare company founded in 1985 with 64,200 employees. The company operates healthcare facilities and provides related medical services.

ATS AUTOMATION TOOLING SYSTEMS INC

ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.

CONVATEC

ConvaTec is a United Kingdom-based public company founded in 1978. The company manufactures and distributes medical devices and healthcare products globally.

IRADIMED CORPORATION

IraMed Corporation is a United States-based public company founded in 1992 with 166 employees. The company specializes in medical imaging and monitoring equipment.

POLY MEDICURE LTD.

Poly Medicure Ltd. is an Indian public company founded in 1995 with 3,082 employees. The company manufactures medical devices and healthcare products.

CONMED CORPORATION

ConMed Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company manufactures and distributes surgical and medical devices.

MALLINCKRODT PLC

Mallinckrodt PLC is an Ireland-based private company with a history dating to 1867 and 2,687 employees. The company operates in the pharmaceutical and medical device sectors.

BECTON, DICKINSON AND COMPANY

Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees. The company is a global leader in medical technology, manufacturing diagnostic and healthcare devices.

BAXTER

Baxter is a United States-based public company founded in 1931 with 37,500 employees. The company develops and manufactures medical devices, pharmaceuticals, and healthcare solutions.

FRESENIUS SE & CO. KGAA

Fresenius SE & Co. KGaA is a German public company founded in 1912 with 177,783 employees. The company is a global healthcare company providing dialysis, infusion therapy, and hospital products.

ICU MEDICAL, INC.

ICU Medical, Inc. is a United States-based public company founded in 1984 with 13,000 employees. The company manufactures critical care medical devices and infusion therapy products.

TERUMO CORPORATION

Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices and healthcare products globally.

MOOG, INC.

Moog, Inc. is a United States-based public company founded in 1951 with 13,500 employees. The company manufactures precision motion and control products for aerospace, defense, and medical applications.

TELEFLEX INCORPORATED

Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees. The company designs and manufactures medical devices for critical care and surgical applications.

SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a Chinese public company founded in 1991 with 21,288 employees. The company manufactures medical devices and diagnostic equipment.

CARDINAL HEALTH

Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees. The company is a global healthcare services and products company serving hospitals and healthcare providers.

AVANOS MEDICAL, INC.

Avanos Medical, Inc. is a United States-based public company founded in 2014 with 2,287 employees. The company manufactures and distributes medical devices for healthcare applications.

NIPRO

Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures medical devices, pharmaceuticals, and healthcare products.

JMS CO., LTD.

JMS Co., Ltd. is a United States-based public company founded in 1897 with 8,000 employees. The company manufactures medical devices and healthcare products.

Reasons to Buy this Report

Market-Specific Sizing & Forecasts : Access precise Malaysia market valuations (USD 29.59M in 2026, USD 37.87M in 2031) with country-specific CAGR of 5.1% to inform investment and expansion decisions.
Competitive Landscape Intelligence : Understand Malaysia's unique competitive dynamics, local player strategies, and market entry barriers specific to the Malaysian healthcare sector.
End-User Demand Analysis : Gain insights into hospital, clinic, and ambulatory care facility requirements across Malaysia to tailor product offerings and distribution strategies.
Regulatory & Healthcare Policy Context : Navigate Malaysia-specific healthcare regulations, reimbursement frameworks, and government initiatives driving IV equipment adoption and market growth.
Growth Opportunity Identification : Identify high-potential segments and geographic pockets within Malaysia for targeted market penetration and revenue maximization strategies.

Frequently asked questions

What is the current size of Malaysia's IV Equipment Market?

Malaysia's IV Equipment Market is estimated at USD 29.59 million in 2026 and is projected to grow to USD 37.87 million by 2031.

What is the growth rate of Malaysia's IV Equipment Market?

Malaysia's IV Equipment Market is growing at a compound annual growth rate (CAGR) of 5.1% from 2026 to 2031.

What factors are driving growth in Malaysia's IV Equipment Market?

Growth in Malaysia's IV Equipment Market is driven by advancing healthcare infrastructure, rising patient volumes, increased healthcare spending, and adoption of modern infusion technologies.

Which segments are growing fastest in Malaysia's IV Equipment Market?

Smart infusion pumps and automated IV delivery systems are among the fastest-growing segments in Malaysia's IV Equipment Market, particularly in tertiary care facilities.

How does Malaysia's IV Equipment Market compare to other Asia Pacific countries?

Malaysia's IV Equipment Market, growing at 5.1% CAGR, represents a significant segment within the Asia Pacific region, supported by strong healthcare infrastructure and regulatory standards.

RESEARCH METHODOLOGY

This study relied heavily on both primary and secondary sources. The research process involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and company SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the IV equipment market. It was also used to obtain important information on key players, market classification & segmentation aligned with industry trends, and key developments from market and technology perspectives, down to the bottom-most level. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from leading companies and organizations in the IV equipment market. The primary demand-side sources include medical OEMs, medical device ISOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends & key market dynamics.

Breakdown of Primary Interviews:

A breakdown of the primary respondents for the IV equipment market (supply side) is provided below:

Note 1: Others include sales, marketing, and product managers.

Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion,

Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

In this report, the global IV equipment market size was determined using the revenue share analysis of leading players. For this purpose, key market players were identified, and their revenues from the IV equipment business were determined using insights gathered during the primary and secondary research phases. Secondary research included analyzing the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, including CEOs, directors, and senior marketing executives.

To calculate the global market value, segmental revenues were derived from the revenue mapping of major solution/service providers. This process involved the following steps:

Generating a list of major global players operating in the IV equipment market
Mapping annual revenues generated by major global players from the IV equipment segment (or nearest reported business unit/service category)
Revenue mapping of key players to cover a major share of the global market as of 2024
Extrapolating the global value of the IV equipment industry

Global IV Equipment Market Size: Top-down & Bottom-up Approach

IV Equipment Market : Top-Down and Bottom-Up Approach

Data Triangulation

After arriving at the overall market size through the market size estimation process explained above, the global IV equipment market was segmented and subsegmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and obtain exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the IV equipment market was validated using both top-down and bottom-up approaches.

Market Definition

IV equipment refers to the complete set of medical devices, accessories, and consumables used to deliver fluids, medications, nutrients, and blood products directly into a patient’s bloodstream through intravenous (IV) access. It includes infusion pumps, IV administration sets, catheters and cannulas, needle-free connectors, extension sets, securement devices, and related safety components designed to ensure accurate, controlled, and sterile delivery of therapies in hospitals, outpatient centers, and home care settings. IV equipment is essential for hydration, drug infusion, chemotherapy, parenteral nutrition, anesthesia, critical care, and emergency treatment.

Key Stakeholders

Manufacturers of IV equipment
Distributors of IV equipment
Hospitals, clinics, and infusion centers
Ambulatory surgery centers
Non-government organizations
Government regulatory authorities
Contract manufacturers & third-party suppliers
Research laboratories & academic institutes
Clinical research organizations (CROs)
Government & non-governmental regulatory authorities
Market research & consulting firms

Report Objectives

To define, describe, and forecast the IV equipment market based on type, application, end user, and region
To provide detailed information regarding the major factors influencing the growth potential of the global IV equipment market (drivers, restraints, opportunities, challenges, and trends)
To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global IV equipment market
To analyze key growth opportunities in the global IV equipment market for key stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the global IV equipment market in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To profile the key players in the global IV equipment market and comprehensively analyze their market shares and core competencies
To track and analyze the competitive developments undertaken in the global IV equipment market, such as agreements, collaborations, partnerships, expansions, and acquisitions

Customization Options

Based on the market data provided, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the present global IV equipment market report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of the top twelve companies

Geographic Analysis

Further breakdown of the Rest of Europe IV equipment market into Russia, Finland, Switzerland, Turkey, the Czech Republic, the Netherlands, Norway, Poland, Portugal, Romania, Estonia, Austria, and Belgium
Further breakdown of the Rest of Asia Pacific IV equipment market into Taiwan, New Zealand, and Sri Lanka
Further breakdown of the Rest of Latin America IV equipment market into Uruguay, Costa Rica, Bolivia, Venezuela, and Paraguay

Get the Full IV Equipment Market Report

Full forecast, segment splits, and company analysis for all IV Equipment Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)